Stay updated with breaking news from 45845p10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Free Report) saw strong trading volume on Wednesday . 673,736 shares traded hands during mid-day trading, a decline of 49% from the previous session’s volume of 1,326,601 shares.The stock last traded at $18.96 and had previously closed at $18.93. Analysts Set New Price Targets A number of […]
Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Free Report) have been assigned an average recommendation of “Hold” from the eight research firms that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average […]
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Free Report) has earned a consensus rating of “Hold” from the eight analysts that are currently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month target price among […]
StockNews.com assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a research note released on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on ICPT. HC Wainwright cut Intercept Pharmaceuticals from a buy rating to a neutral […]
Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) had its target price increased by Royal Bank of Canada from $12.00 to $19.00 in a research report sent to investors on Wednesday morning, Marketbeat.com reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. Several other analysts also recently issued reports on ICPT. Canaccord Genuity […]